Showing results (231-240 of 244) with videos related to
Sort By:
Pageof 25
Biorxiv : the Preprint Server for Biology|December 10, 2020
Designed proteins assemble antibodies into modular nanocagesRobby Divine, Ha V Dang, George Ueda, et al.Nature|June 18, 2025
R9AP is a common receptor for EBV infection in epithelial cells and B cellsYan Li, Hua Zhang, Cong Sun, et al.Biorxiv : the Preprint Server for Biology|April 1, 2021
Live Imaging of SARS-CoV-2 Infection in Mice Reveals Neutralizing Antibodies Require Fc Function for Optimal EfficacyIrfan Ullah, Jérémie Prévost, Mark S Ladinsky, et al.Immunity|August 28, 2021
Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacyIrfan Ullah, Jérémie Prévost, Mark S Ladinsky, et al.Cell Reports|July 8, 2021
Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjectsMadeleine F Jennewein, Anna J MacCamy, Nicholas R Akins, et al.Cell Host & Microbe|June 16, 2021
A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responsesAlexandra Tauzin, Manon Nayrac, Mehdi Benlarbi, et al.Biorxiv : the Preprint Server for Biology|March 24, 2021
A single BNT162b2 mRNA dose elicits antibodies with Fc-mediated effector functions and boost pre-existing humoral and T cell responsesAlexandra Tauzin, Manon Nayrac, Mehdi Benlarbi, et al.Biorxiv : the Preprint Server for Biology|April 1, 2021
Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ SubjectsMadeleine F Jennewein, Anna J MacCamy, Nicholas R Akins, et al.Nature|May 31, 2019
Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaquesAmelia Escolano, Harry B Gristick, Morgan E Abernathy, et al.Science Immunology|February 10, 2023
CD4 binding site immunogens elicit heterologous anti-HIV-1 neutralizing antibodies in transgenic and wild-type animalsHarry B Gristick, Harald Hartweger, Maximilian Loewe, et al.Pageof 25